Cardiff Oncology
(NASDAQ) CRDF
Cardiff Oncology Financials at a Glance
Market Cap
$123.06M
Revenue (TTM)
$593.00K
Net Income (TTM)
$45.85M
EPS (TTM)
$-0.69
P/E Ratio
-2.62
Dividend
$0.00
Beta (Volatility)
1.67 (High)
Dividend
$0.00
Beta (Volatility)
1.67 (High)
Price
$1.78
Volume
10,045
Open
$1.82
Price
$1.78
Volume
10,045
Open
$1.82
Previous Close
$1.78
Daily Range
$1.78 - $1.86
52-Week Range
$1.48 - $4.55
Dividend
$0.00
Beta (Volatility)
1.67 (High)
Price
$1.78
Volume
10,045
Open
$1.82
Previous Close
$1.78
Daily Range
$1.78 - $1.86
52-Week Range
$1.48 - $4.55
CRDF News
CRDF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cardiff Oncology
Industry
Biotechnology
Sector
Health CareEmployees
31
CEO
Mark Erlander, PhD
Website
www.cardiffoncology.comHeadquarters
San Diego, CA 92121, US
CRDF Financials
Key Financial Metrics (TTM)
Gross Margin
-19%
Operating Margin
-83%
Net Income Margin
-77%
Return on Equity
-71%
Return on Capital
-1%
Return on Assets
-74%
Earnings Yield
-38.17%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$123.06M
Shares Outstanding
68.36M
Volume
10.04K
Short Interest
0.00%
Avg. Volume
1.16M
Financials (TTM)
Gross Profit
$311.00K
Operating Income
$48.96M
EBITDA
$44.97M
Operating Cash Flow
$37.92M
Capital Expenditure
$44.00K
Free Cash Flow
$37.97M
Cash & ST Invst.
$58.30M
Total Debt
$832.00K
Cardiff Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$243.00K
+60.9%
Gross Profit
$20.00K
-86.8%
Gross Margin
8.23%
N/A
Market Cap
$123.06M
N/A
Market Cap/Employee
$3.85M
N/A
Employees
32
N/A
Net Income
$7.22M
+38.8%
EBITDA
$6.99M
+44.0%
Quarterly Fundamentals
Net Cash
$57.47M
-36.3%
Accounts Receivable
$182.00K
-76.5%
Inventory
$0.00
N/A
Long Term Debt
$102.00K
-87.5%
Short Term Debt
$730.00K
+2.8%
Return on Assets
-74.09%
N/A
Return on Invested Capital
-1.08%
N/A
Free Cash Flow
$5.97M
+41.9%
Operating Cash Flow
$5.97M
+41.9%